DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 245 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2024. The put-call ratio across all filers is 2.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $122,407,000 | +7.9% | 10,900,000 | +19.2% | 3.65% | +12.4% |
| Q1 2024 | $113,448,001 | +14.4% | 9,141,660 | +28.9% | 3.25% | -1.9% |
| Q4 2023 | $99,163,132 | -0.6% | 7,093,214 | +5.0% | 3.31% | -14.0% |
| Q3 2023 | $99,800,240 | +17.8% | 6,756,956 | +3.0% | 3.85% | -1.8% |
| Q2 2023 | $84,726,983 | +36.0% | 6,557,816 | +3.3% | 3.92% | +53.3% |
| Q1 2023 | $62,293,500 | +151.5% | 6,350,000 | +172.8% | 2.56% | +146.0% |
| Q4 2022 | $24,769,399 | – | 2,327,951 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |